Juan Antonio García Velasco_IVIRMA Madrid_c
Contact info:
Juan García Velasco, M.D., Ph.D.

Biography

Juan García-Velasco, MD, PhD, is Director of IVI Madrid, where he attends his patients. He is also Professor of Obstetrics and Gynaecology at Rey Juan Carlos University, Madrid, Spain, where he is Director of their Master’s Degree Programme in Human Reproduction.

Professor García-Velasco graduated from University Medical School, Madrid, in 1990 and received his obstetrics and gynaecology certification from La Paz Hospital, Madrid, in 1995. He completed his PhD in Medicine at Autonoma University, Madrid, in 1995, and from 1997 to 1998 studied at Yale University, New Haven, CT, under a Reproductive Endocrinology and Infertility Fellowship.

Professor García-Velasco’s main research interests have been in IVF and endometriosis. He is the Principal Investigator of projects funded by the Ministry of Education and Ministry of Health in Spain, and has received awards from the Spanish Fertility Society, Spanish Society of Obstetrics and Gynaecology, and the European Society of Human Reproduction and Embryology. He has published over 190 peer-reviewed articles and 22 book chapters on human reproduction, endometriosis and hypo- and hyper-ovarian stimulation response. He is the Co-Editor of Reproductive Biomedicine Online.


Read more

Education and Training

Complutense University Medical School, Madrid Spain 1990
Ob/Gyn Board Certified La Paz Hospital 1992-1995
PhD degree in Medicine Autonoma University Madrid Spain, 1995
Fellowship in Reproductive Endocrinology & Infertility Yale University, USA 1997/98
Full Professor of Obstetrics and Gynecology Rey Juan Carlos University, Madrid, Spain
Director of the Master in Human Reproduction Rey Juan Carlos University and IVI

Honors and recognition

Spanish Fertility Society (1999 y 2009)
Spanish Ob/Gyn Society (1997)
ESHRE (2011)
 

Research activity:

191 peer reviewed articles, 22 book chapters and 4 edited books.

Publications


  • Review the 'peer review'.
    Blockeel C, Drakopoulos P, Polyzos NP, Tournaye H, García-Velasco JA.
    Reprod Biomed Online. 2017.

  • Dual Triggering With Gonadotropin-Releasing Hormone Agonist and Standard Dose Human Chorionic Gonadotropin in Patients With a High Immature Oocyte Rate.
    Fabris AM, Cruz M, Legidos V, Iglesias C, Muñoz M, García-Velasco JA.
    Reprod Sci, 24:1221-1225, 2017.

  • Endometrial receptivity in eutopic endometrium in patients with endometriosis: it is not affected, and let me show you why.
    Miravet-Valenciano J, Ruiz-Alonso M, Gómez E, Garcia-Velasco JA.
    Fertil Steril. 108:28-31, 2017.

  • Impact of vitamin D levels on ovarian reserve and ovarian response to ovarian stimulation in oocyte donors.
    Fabris AM, Cruz M, Iglesias C, Pacheco A, Patel A, Patel J, Fatemi H, García-Velasco JA.
    Reprod Biomed Online.35:139-144, 2017.

  • Type of gonadotropin used during controlled ovarian stimulation induces differential gene expression in human cumulus cells: A randomized study.
    Cruz M, Requena A, Agudo D, García-Velasco JA.
    Eur J Obstet Gynecol Reprod Biol. 215:124-133, 2017.

  • Why natural killer cells are not enough: a further understanding of killer immunoglobulin-like receptor and human leukocyte antigen.
    Alecsandru D, García-Velasco JA.
    Fertil Steril. 107:1273-1278, 2017.

  • Introduction: Immunology and assisted reproductive technology in the 21st century.
    Garcia-Velasco JA.
    Fertil Steril.107:1267-1268, 2017.

  • What fertility specialists should know about the vaginal microbiome: a review.
    García-Velasco JA, Menabrito M, Catalán IB.
    Reprod Biomed Online. 35:103-112, 2017.

  • Breast cancer risk after oocyte donation: should we really be concerned?
    Fauser BC, Garcia Velasco J.
    Reprod Biomed Online. 34:439-440, 2017.

  • Impact of Endometrial Preparation Protocols for Frozen Embryo Transfer on Live Birth Rates.
    Cerrillo M, Herrero L, Guillén A, Mayoral M, García-Velasco JA.
    Rambam Maimonides Med J. 2017.

  • Impact of very low anti-Müllerian hormone on pregnancy success.
    Pacheco A, Cruz M, García Velasco JA.
    Curr Opin Obstet Gynecol. 29:131-135, 2017.

  • A bright future.
    Fauser B, Alikani M, Franklin S, Johnson MH, Garcia-Velasco J.
    Reprod Biomed Online. 34:1-2., 2017.

  • A cost-effectiveness evaluation comparing originator follitropin alfa to the biosimilar for the treatment of infertility.
    Gizzo S, Garcia-Velasco JA, Heiman F, Ripellino C, Bühler K.
    Int J Womens Health. 8:683-689, 2016.

  • Individualized versus conventional ovarian stimulation for in vitro fertilization: a multicenter, randomized, controlled, assessor-blinded, phase 3 noninferiority trial.
    Nyboe Andersen A, Nelson SM, Fauser BC, García-Velasco JA, Klein BM, Arce JC; ESTHER-1 study group.
    Fertil Steril. 107:387-396, 2017.

  • Oocyte cryopreservation for fertility preservation in women with cancer.
    Domingo J, Garcia-Velasco JA.
    Curr Opin Endocrinol Diabetes Obes. 23:465-469,2016.

  • Adenomyosis in infertile women: prevalence and the role of 3D ultrasound as a marker of severity of the disease.
    Puente JM, Fabris A, Patel J, Patel A, Cerrillo M, Requena A, Garcia-Velasco JA.
    Reprod Biol Endocrinol. 14:60, 2016.

  • The state of "freeze-for-all" in human ARTs.
    Basile N, Garcia-Velasco JA.
    J Assist Reprod Genet. 33:1543-1550, 2016.

  • Response: in reference to 'Strategies to manage refractory endometrium: state of the art 2016'.
    Garcia-Velasco JA, Acevedo B, Alvarez C, Alvarez M, Bellver J, Fontes J, Landeras J, Manau D, Martinez F, Muñoz E, Robles A, Rodriguez-Tabernero L.
    Reprod Biomed Online. 33: 605, 2016.

  • Excessive Age-Related Decline in Functional Ovarian Reserve in Infertile Women: Prospective Cohort of 15,500 Women.
    Iliodromiti S, Iglesias Sanchez C, Messow CM, Cruz M, Garcia Velasco J, Nelson SM.
    J Clin Endocrinol Metab. 101:3548-54, 2016.

  • Ethnicity is an independent predictor of IVF-ICSI outcome: a study of 5,549 cycles in Spain and India.
    Patel AP, Patel JA, Cruz M, Gupte-Shah A, Garcia Velasco JA, Banker MR.
    Gynecol Endocrinol. 32:819-822, 2016.

  • IVF: progress through technology development.
    Seli E, Garcia-Velasco J.
    Curr Opin Obstet Gynecol. 28:149-50, 2016.

  • Preimplantation genetic screening - what a wonderful world it would be!
    Garcia-Velasco JA, Fauser BC.
    Reprod Biomed Online. 32:337-8. 2016.

  • Why all women should freeze their eggs.
    Cobo A, García-Velasco JA.
    Curr Opin Obstet Gynecol. 28:206-10, 2016.

  • Strategies to manage refractory endometrium: state of the art in 2016.
    Garcia-Velasco JA, Acevedo B, Alvarez C, Alvarez M, Bellver J, Fontes J, Landeras J, Manau D, Martinez F, Muñoz E, Robles A, Rodriguez-Tabernero L.
    Reprod Biomed Online. 32:474-89, 2016.

  • Assisted reproductive techniques after fertility-sparing treatments in gynaecological cancers.
    Zapardiel I, Cruz M, Diestro MD, Requena A, Garcia-Velasco JA.
    Hum Reprod Update. 2016.

  • Type of gonadotropin during controlled ovarian stimulation affects the endocrine profile in follicular fluid and apoptosis rate in cumulus cells.
    Requena A, Cruz M, Agudo D, Pacheco A, García-Velasco JA.
    Eur J Obstet Gynecol Reprod Biol. 197:142-6, 2016.

  • Oocyte vitrification as an efficient option for elective fertility preservation.
    Cobo A, García-Velasco JA, Coello A, Domingo J, Pellicer A, Remohí J.
    Fertil Steril. 105:755-764, 2016.

  • Meet our new editor.
    García-Velasco JA.
    Reprod Biomed Online. 31:717, 2015.

  • The necessity to define the sub-optimal responders.
    García-Velasco JA, Bosch E.
    Hum Reprod. 30:2958, 2015.

  • Absence of luteal phase defect and spontaneous pregnancy in IVF patients despite GnRH-agonist trigger and "freeze all policy" without luteal phase support: a report of four cases.
    Gurbuz AS, Deveer R, Ozcimen N, Ozcimen EE, Lawrenz B, Banker M, García-Velasco JA, Fatemi HM.
    Gynecol Endocrinol. 32:18-20, 2015.

  • Comprehensive chromosome screening improves embryo selection: a meta-analysis.
    Dahdouh EM, Balayla J, García-Velasco JA.
    Fertil Steril. 104:1503-12, 2015.

  • Is endometrial receptivity transcriptomics affected in women with endometriosis? A pilot study.
    García-Velasco JA, Fassbender A, Ruiz-Alonso M, Blesa D, D'Hooghe T, Simon C.
    Reprod Biomed Online. 31:647-54, 2015.

  • Treatment of infertility associated with deep endometriosis: definition of therapeutic balances.
    Somigliana E, García-Velasco JA.
    Fertil Steril. 104:764-770, 2015.

  • Follicular and endocrine dose responses according to anti-Müllerian hormone levels in IVF patients treated with a novel human recombinant FSH (FE 999049).
    Bosch E, Nyboe Andersen A, Barri P, García-Velasco JA, de Sutter P, Fernández-Sánchez M, Visnova H, Klein BM, Mannaerts B, Arce JC.
    Clin Endocrinol (Oxf). 83:902-12, 2015.

  • To pill or not to pill in GnRH-antagonist cycles: still an open debate.
    García-Velasco JA, Fatemi H.
    Reprod Biomed Online. 31:445, 2015.

  • Ongoing pregnancy rates in intrauterine insemination are affected by late follicular-phase progesterone levels.
    Requena A, Cruz M, Pacheco A, García-Velasco JA.
    Fertil Steril. 104:879-883, 2015.

  • Progesterone supplementation in the frozen embryo transfer cycle.
    Ortega I, García-Velasco JA.
    Curr Opin Obstet Gynecol. 27:253-7, 2015.

  • Immune testing and treatment: still an open debate.
    Alecsandru D, García-Velasco JA.
    Hum Reprod. 30:1994, 2015.

  • IVF: a short but exciting story.
    García-Velasco JA, Seli E.
    Curr Opin Obstet Gynecol. 27:165-6, 2015.

  • The updated Cochrane review 2014 on GnRH agonist trigger: repeating the same errors.
    Kol S, Humaidan P, Alsbjerg B, Engmann L, Benadiva C, García-Velasco JA, Fatemi H, Andersen CY.
    Reprod Biomed Online. 30:563-5, 2015.

  • Preimplantation genetic screening using comprehensive chromosome screening: evidence and remaining challenges.
    Dahdouh EM, Balayla J, García-Velasco JA.
    Hum Reprod. 30:1515-6, 2015.

  • Revisiting ovarian hyper stimulation syndrome: Towards OHSS free clinic.
    Banker M, García-Velasco JA.
    J Hum Reprod Sci. 8:13-7, 2015.

  • Immunology and human reproduction.
    Alecsandru D, García-Velasco JA.
    Curr Opin Obstet Gynecol. 27:231-4, 2015.

  • A multi-centre phase 3 study comparing efficacy and safety of Bemfola(®) versus Gonal-f(®) in women undergoing ovarian stimulation for IVF.
    Rettenbacher M, Andersen AN, García-Velasco JA, Sator M, Barri P, Lindenberg S, van der Ven K, Khalaf Y, Bentin-Ley U, Obruca A, Tews G, Schenk M, Strowitzki T, Narvekar N, Sator K, Imthurn B.
    Reprod Biomed Online. 30:504-13, 2015.

  • Avoiding ovarian hyperstimulation syndrome with the use of gonadotropin-releasing hormone agonist trigger.
    Fatemi HM, García-Velasco JA.
    Fertil Steril. 103:870-3, 2015.

  • Scheduling cycles with gonadotropin-releasing hormone antagonist protocol in in vitro fertilization: Is there a scope in batch in vitro fertilization?
    Gutgutia R, Rao S, García-Velasco JA, Basu S.
    J Hum Reprod Sci. 7:230-5, 2014.

  • Impact of blastocyst biopsy and comprehensive chromosome screening technology on preimplantation genetic screening: a systematic review of randomized controlled trials.
    Dahdouh EM, Balayla J,García-Velasco JA.
    Reprod Biomed Online. 30:281-9, 2015.

  • The use of morphokinetics as a predictor of  implantation: a multicentric study to define and validate an algorithm for embryo selection.
    Basile N, Vime P, Florensa M, Aparicio Ruiz B, García-Velasco JA, Remohí J, Meseguer M.
    Hum Reprod. 30:276-83, 2015.

  • Is there a relationship between time-lapse parameters and embryo sex?
    Bronet F, Nogales MC, Martínez E, Ariza M, Rubio C, García-Velasco JA, Meseguer M.
    Fertil Steril. 103:396-401. 2015.

  • Vitamin D and in vitro fertilization outcome.
    García-Velasco JA, Iglesias C, Fabris A.
    Am J Obstet Gynecol. 212:412-3, 2015.

  • To pill or not to pill in GnRH antagonist cycles: that is the question!
    García-Velasco JA, Fatemi HM.
    Reprod Biomed Online. 30:39-42, 2015.

  • Obstetric outcome after oocyte vitrification and warming for fertility preservation in women with cancer.
    Martinez M, Rabadan S, Domingo J, Cobo A, Pellicer A, García-Velasco JA.
    Reprod Biomed Online. 29:722-8, 2014.

  • Oocyte donation outcome after oncological treatment in cancer survivors.
    Muñoz E, Fernandez I, Martinez M, Tocino A, Portela S, Pellicer A, García-Velasco JA, Garrido N.
    Fertil Steril. 103:205-13, 2015.

  • Maternal KIR haplotype influences live birth rate after double embryo transfer in IVF cycles in patients with recurrent miscarriages and implantation failure.
    Alecsandru D, Garrido N, Vicario JL, Barrio A, Aparicio P, Requena A, García-Velasco JA.
    Hum Reprod. 29:2637-43, 2014.

  • Ovarian response to recombinant human follicle-stimulating hormone: a randomized, antimüllerian hormone-stratified, dose-response trial in women undergoing in vitro fertilization/intracytoplasmic sperm injection.
    Arce JC, Andersen AN, Fernández-Sánchez M, Visnova H, Bosch E, García-Velasco JA, Barri P, de Sutter P, Klein BM, Fauser BC.
    Fertil Steril. 102:1633-40, 2014.

  • Impact of circulating levels of total and bioavailable serum vitamin D on pregnancy rate in egg donation recipients.
    Fabris A, Pacheco A, Cruz M, Puente JM, Fatemi H, García-Velasco JA.
    Fertil Steril. 102:1608-12, 2014.

  • Response: poor responders and androgen adjuvant treatment: "still haven't found what I'm looking for…".
    García-Velasco JA
    Reprod Biomed Online. 29:653-4, 2014.

  • Oocyte versus embryo vitrification for delayed embryo transfer: an observational study.
    Herrero L, Pareja S, Aragonés M, Cobo A, Bronet F, García-Velasco JA.
    Reprod Biomed Online. 29:567-72, 2014.

  • High progesterone levels in women with high ovarian response do not affect clinical outcomes: a retrospective cohort study.
    Requena A, Cruz M, Bosch E, Meseguer M, García-Velasco JA.
    Reprod Biol Endocrinol. 26:12-69, 2014.

  • Poor responders and androgen adjuvant treatment: "Still haven't found what I'm looking for...".
    García-Velasco JA
    Reprod Biomed Online.28:661-2, 2014.

  • Ethnicity as a determinant of ovarian reserve: differences in ovarian aging between Spanish and Indian women.
    Iglesias C, Banker M, Mahajan N, Herrero L, Meseguer M, García-Velasco JA.
    Fertil Steril. 102:244-9, 2014.

  • The impact of using the combined oral contraceptive pill for cycle scheduling on gene expression related to endometrial receptivity.
    Bermejo A, Iglesias C, Ruiz-Alonso M, Blesa D, Simón C, Pellicer A, García-Velasco JA.
    Hum Reprod. 29:1271-8,2014.

  • Severe ovarian hyperstimulation syndrome after gonadotropin-releasing hormone (GnRH) agonist trigger and "freeze-all" approach in GnRH antagonist protocol.
    Fatemi HM, Popovic-Todorovic B, Humaidan P, Kol S, Banker M, Devroey P, García-Velasco JA.
    Fertil Steril. 101:1008-11, 2014.

  • Endocrine profile following stimulation with recombinant follicle stimulating hormone and luteinizing hormone versus highly purified human menopausal gonadotropin.
    Requena A, Cruz M, Ruiz FJ, García-Velasco JA.
    Reprod Biol Endocrinol. 29;12:10, 2014.

  • Successful ICSI in an azoospermic and kidney transplant man with type 1 primary hyperoxaluria and first histopathological testicular findings described in the literature.
    Balmori C, Guillén A, Montans J, Bronet F,García-Velasco JA.
    Andrologia. 47:109-11, 2015.

  • Increasing the probability of selecting chromosomally normal embryos by time-lapse morphokinetics analysis.
    Basile N, Nogales Mdel C, Bronet F, Florensa M, Riqueiros M, Rodrigo L, García-Velasco JA, Meseguer M.
    Fertil Steril. 101:699-704, 2014.

  • Successful twin delivery following transmyometrial embryo transfer in a patient with a false uterine cavity.
    Muñoz M, Galindo N, Pérez-Cano I, Cruz M, García-Velasco JA.
    Reprod Biomed Online. 28:137-40, 2014.

  • Impact of final oocyte maturation using gonadotropin-releasing hormone agonist triggering and different luteal support protocols on endometrial gene expression.
    Bermejo A, Cerrillo M, Ruiz-Alonso M, Blesa D, Simón C, Pellicer A, García-Velasco JA.
    Fertil Steril. 101:138-146, 2014.

  • Cycle scheduling for in vitro fertilization with oral contraceptive pills versus oral estradiol valerate: a randomized, controlled trial.
    Hauzman EE, Zapata A, Bermejo A, Iglesias C, Pellicer A, García-Velasco JA.
    Reprod Biol Endocrinol. 28; 11:96, 2013.

  • Obesity reduces uterine receptivity: clinical experience from 9,587 first cycles of ovum donation with normal weight donors.
    Bellver J, Pellicer A, García-Velasco JA, Ballesteros A, Remohí J, Meseguer M.
    Fertil Steril. 100:1050-8, 2013

  • GnRH-agonist triggering to avoid ovarian hyperstimulation syndrome: a review of the evidence.
    Martinez MC, Ruiz FJ, García-Velasco JA.
    Curr Drug Targets. 14:843-9, 2013

  • Is vitrification of oocytes useful for fertility preservation for age-related fertility decline and in cancer patients?
    Cobo A, García-Velasco JA, Domingo J, Remohí J, Pellicer A.
    Fertil Steril. 99:1485-95, 2013.

  • Five years' experience using oocyte vitrification to preserve fertility for medical and nonmedical indications.
    García-Velasco JA, Domingo J, Cobo A, Martínez M, Carmona L, Pellicer A.
    Fertil Steril. 99:1994-9, 2013.

  • Oocyte donation and endometriosis: What are the lessons?
    Hauzman EE, García-Velasco JA, Pellicer A.
    Semin Reprod Med. 31:173-7, 2013.

  • In vitro fertilization outcome in women with unoperated bilateral endometriomas.
    Benaglia L, Bermejo A, Somigliana E, Faulisi S, Ragni G, Fedele L, García-Velasco JA.
    Fertil Steril. 99:1714-9, 2013.

  • Evaluation of the degree of satisfaction in oocyte donors using sustained-release FSH corifollitropin α.
    Requena A, Cruz M, Collado D, Izquierdo A, Ballesteros A, Muñoz M, García-Velasco JA.
    Reprod Biomed Online. 26:253-9, 2013.

  • Type of culture media does not affect embryo kinetics: a time-lapse analysis of sibling oocytes.
    Basile N, Morbeck D, García-Velasco JA, Bronet F, Meseguer M.
    Hum Reprod. 28:634-41, 2013.

  • The use of aromatase inhibitors in in vitro fertilization.
    García-Velasco JA.
    Fertil Steril. 98:1356-8, 2012.

  • FSH receptor in vitro modulation by testosterone and hCG in human luteinized granulosa cells.
    García-Velasco JA, Rodríguez S, Agudo D, Pacheco A, Schneider J, Pellicer A.
    Eur J Obstet Gynecol Reprod Biol. 165:259-64, 2012.

  • Early progesterone cessation after in vitro fertilization/intracytoplasmic sperm injection: a randomized, controlled trial.
    Kohls G, Ruiz F, Martínez M, Hauzman E, de la Fuente G, Pellicer A, García-Velasco JA.
    Fertil Steril. 98:858-62, 2012.

  • Analysis of follicular fluid and serum markers of oxidative stress in women with infertility related to endometriosis.
    Prieto L, Quesada JF, Cambero O, Pacheco A, Pellicer A, Codoceo R, García-Velasco JA.
    Fertil Steril. 98:126-30, 2012.

  • Sperm DNA fragmentation index does not correlate with the sperm or embryo aneuploidy rate in recurrent miscarriage or implantation failure patients.
    Bronet F, Martínez E, Gaytán M, Liñán A, Cernuda D, Ariza M, Nogales M, Pacheco A, San Celestino M, García-Velasco JA.
    Hum Reprod. 27:1922-9, 2012.

  • Pregnancy outcome in women with endometriomas achieving pregnancy through IVF.
    Benaglia L, Bermejo A, Somigliana E, Scarduelli C, Ragni G, Fedele L, García-Velasco JA.
    Hum Reprod. 27:1663-7, 2012.

  • Patients from across Europe have similar views on patient-centred care: an international multilingual qualitative study in infertility care.
    Dancet EA, D'Hooghe TM, Sermeus W, van Empel I, Strohmer H, Wyns C, Santa-Cruz D, Nardo LG, Kovatchki D, Vanlangenakker L, García-Velasco JA, Mulugeta B, Nelen WL, Kremer JA.
    Hum Reprod. 27:1702-11, 2012.

  • Is there a benefit for surgery in endometrioma-associated infertility?
    Ruiz-Flores FJ,García-Velasco JA.
    Curr Opin Obstet Gynecol. 24:136-40, 2012.

  • Understanding the perceptions of and emotional barriers to infertility treatment: a survey in four European countries.
    Domar A, Gordon K, García-Velasco JA, La Marca A, Barriere P, Beligotti F.
    Hum Reprod. 27:1073-9, 2012.

  • Ovarian response to controlled ovarian hyperstimulation in cancer patients is diminished even before oncological treatment.
    Domingo J, Guillén V, Ayllón Y, Martínez M, Muñoz E, Pellicer A, García-Velasco JA.
    Fertil Steril. 97:930-4, 2012.

  • Empty follicle syndrome after GnRHa triggering versus hCG triggering in COS.
    Castillo JC, García-Velasco JA, Humaidan P.
    J Assist Reprod Genet. 29:249-53, 2012.

  • Agonist trigger: what is the best approach? Agonist trigger with vitrification of oocytes or embryos.
    García-Velasco JA.
    Fertil Steril. 97:527-8, 2012.

  • Follicular and endocrine profiles associated with different GnRH-antagonist regimens: a randomized controlled trial.
    García-Velasco JA, Kupesic S, Pellicer A, Bourgain C, Simón C, Mrazek M, Devroey P, Arce JC.
    Reprod Biomed Online. 24:153-62, 2012.

  • The effects of ergot and non-ergot-derived dopamine agonists in an experimental mouse model of endometriosis.
    Delgado-Rosas F, Gómez R, Ferrero H, Gaytan F, García-Velasco JA, Simón C, Pellicer A.
    Reproduction.142:745-55, 2011.

  • Current status of human oocyte and embryo cryopreservation.
    Herrero L, Martínez M, García-Velasco JA.
    Curr Opin Obstet Gynecol. 23:245-50, 2011.

  • Cycle scheduling with oral contraceptive pills in the GnRH antagonist protocol vs the long protocol: a randomized, controlled trial.
    García-Velasco JA, Bermejo A, Ruiz F, Martinez-Salazar J, Requena A, Pellicer A.
    Fertil Steril. 96:590-3, 2011.

  • High-dose recombinant LH add-back strategy using high-dose GnRH antagonist is an innovative protocol compared with standard GnRH antagonist.
    García-Velasco JA, Bennink HJ, Epifanio R, Escudero E, Pellicer A, Simón C.
    Reprod Biomed Online. Feb;22 Suppl 1:S52-9, 2011.

  • GnRH agonist for triggering of final oocyte maturation: time for a change of practice?
    Humaidan P, Kol S, Papanikolaou EG; Copenhagen GnRH Agonist Triggering Workshop Group.
    Hum Reprod Update. 17:510-24, 2011.

  • Effect of GnRH agonist and hCG treatment on VEGF, angiopoietin-2, and VE-cadherin: trying to explain the link to ovarian hyperstimulation syndrome.
    Cerrillo M, Pacheco A, Rodríguez S, Gómez R, Delgado F, Pellicer A, García-Velasco JA.
    Fertil Steril. 95:2517-9, 2011.

  • Physiology and pathology of ovarian hyperstimulation syndrome.
    Gómez R, Soares SR, Busso C, García-Velasco JA, Simón C, Pellicer A.
    Semin Reprod Med. 28:448-57, 2010.

  • Avoiding the use of human chorionic gonadotropin combined with oocyte vitrification and GnRH agonist triggering versus coasting: a new strategy to avoid ovarian hyperstimulation syndrome.
    Herrero L, Pareja S, Losada C, Cobo AC, Pellicer A, García-Velasco JA
    Fertil Steril. 95:1137-40, 2011.

  • Vitrification versus slow freezing of oocytes: effects on morphologic appearance, meiotic spindle configuration, and DNA damage.
    Martínez-Burgos M, Herrero L, Megías D, Salvanes R, Montoya MC, Cobo AC, García-Velasco JA.
    Fertil Steril. 95:374-7, 2011.

  • Low-dose human chorionic gonadotropin versus estradiol/progesterone luteal phase support in gonadotropin-releasing hormone agonist-triggered assisted reproductive technique cycles: understanding a new approach.
    García-Velasco JA, Motta L, López A, Mayoral M, Cerrillo M, Pacheco A.
    Fertil Steril. 94:2820-3, 2010.

  • Identification and quantification of dopamine receptor 2 in human eutopic and ectopic endometrium: a novel molecular target for endometriosis therapy.
    Novella-Maestre E, Carda C, Ruiz-Sauri A, García-Velasco JA, Simon C, Pellicer A.
    Biol Reprod. 83:866-73, 2010.

  • Human follicular fluid from superovulated women inhibits progesterone receptor-dependent gonadotropin-releasing hormone self-priming in an estrous cycle-dependent manner in the rat.
    Gordon A, Aguilar R, Garrido-Gracia JC, Bellido C, Millán Y, Guil-Luna S, García-Velasco JA, Bellido-Muñoz E, de las Mulas JM, Sánchez-Criado JE.
    J Endocrinol Invest. 33:564-70, 2010.

  • The non-ergot derived dopamine agonist quinagolide in prevention of early ovarian hyperstimulation syndrome in IVF patients: a randomized, double-blind, placebo-controlled trial.
    Busso C, Fernández-Sánchez M, García-Velasco JA, Landeras J, Ballesteros A, Muñoz E, González S, Simón C, Arce JC, Pellicer A.
    Hum Reprod. 25:995-1004, 2010.

  • GnRH antagonist ganirelix prevents premature luteinization in IUI cycles: rationale for its use.
    Martinez-Salazar J, Cerrillo M, Quea G, Pacheco A, García-Velasco JA.
    Reprod Biomed Online. 19:156-61, 2009.

  • Comprehensive proteomic analysis of human endometrial fluid aspirate.
    Casado-Vela J, Rodriguez-Suarez E, Iloro I, Ametzazurra A, Alkorta N, García-Velasco JA, Matorras R, Prieto B, González S, Nagore D, Simón L, Elortza F.
    J Proteome Res. 8:4622-32, 2009.

  • Circulating estradiol defines the tumor phenotype in menopausal breast cancer patients.
    Schneider J, Martín-Gutiérrez S, Tresguerres JA, García-Velasco JA.
    Maturitas. 64:43-5, 2009.

  • Symposium: Update on prediction and management of OHSS. Prevention of OHSS--dopamine agonists.
    Busso CE,García-Velasco JA, Gomez R, Alvarez C, Simón C, Pellicer A.
    Reprod Biomed Online. 19:43-51, 2009.

  • The impact of in-vitro maturation of oocytes on aneuploidy rate.
    Requena A, Bronet F, Guillén A, Agudo D, Bou C, García-Velasco JA.
    Reprod Biomed Online. 18:777-83, 2009.

  • How to avoid ovarian hyperstimulation syndrome: a new indication for dopamine agonists.
    García-Velasco JA.
    Reprod Biomed Online. 18 Suppl 2:71-5, 2009.

  • Dopamine agonist administration causes a reduction in endometrial implants through modulation of angiogenesis in experimentally induced endometriosis.
    Novella-Maestre E, Carda C, Noguera I, Ruiz-Saurí A, García-Velasco JA, Simón C, Pellicer A.
    Hum Reprod. 24:1025-35, 2009.

  • Improving the patient's experience of IVF/ICSI: a proposal for an ovarian stimulation protocol with GnRH antagonist co-treatment.
    Devroey P, Aboulghar M, García-Velasco JA, Griesinger G, Humaidan P, Kolibianakis E, Ledger W, Tomás C, Fauser BC.
    Hum Reprod. 24:764-74, 2009.

  • Endometrial fluid is a specific and non-invasive biological sample for protein biomarker identification in endometriosis.
    Ametzazurra A, Matorras R, García-Velasco JA, Prieto B, Simón L, Martínez A, Nagore D.
    Hum Reprod. 24:954-65, 2009.

  • Management of endometriomas in women requiring IVF: to touch or not to touch.
    García-Velasco JA, Somigliana E.
    Hum Reprod. 24:496-501, 2009.

  • Differential regulation of VEGF after final oocyte maturation with GnRH agonist versus hCG: a rationale for OHSS reduction.
    Cerrillo M, Rodríguez S, Mayoral M, Pacheco A, Martínez-Salazar J, García-Velasco JA.
    Fertil Steril. 91(4 Suppl):1526-8, 2009.

  • Letrozole administration during the luteal phase after ovarian stimulation impacts corpus luteum function: a randomized, placebo-controlled trial.
    García-Velasco JA, Quea G, Piró M, Mayoral M, Ruiz M, Toribio M, Requena A.
    Fertil Steril. 92:222-5, 2009.

  • GnRH analogue for the prevention of ovarian hyperstimulation syndrome: a pilot study.
    Giles J, Requena A, García-Velasco JA, Pacheco A, Pellicer J, Pellicer A.
    Fertil Steril. 91(4 Suppl):1366-9, 2009.

  • Targeting the vascular endothelial growth factor system to prevent ovarian hyperstimulation syndrome.
    Soares SR, Gómez R, Simón C, García-Velasco JA, Pellicer A.
    Hum Reprod Update. 14:321-33, 2008.

  • Endocrine modifications associated with final oocyte maturation with gonadotropin-releasing hormone agonists vs. human chorionic gonadotropin in women undergoing intrauterine insemination.
    Díaz I, Guillén A, Pacheco A, Requena A, García-Velasco JA.
    J Reprod Med. 53:33-9, 2008.

  • Soluble vascular endothelial-cadherin levels correlate with clinical and biological aspects of severe ovarian hyperstimulation syndrome.
    Villasante A, Pacheco A, Pau E, Ruiz A, Pellicer A, García-Velasco JA.
    Hum Reprod. 23:662-7, 2008.

  • Estradiol supplementation during the luteal phase of IVF-ICSI patients: a randomized, controlled trial.
    Serna J, Cholquevilque JL, Cela V, Martínez-Salazar J, Requena A, García-Velasco JA.
    Fertil Steril. 90:2190-5, 2008.

  • Cancer treatment and fertility: a time to reassess realistic opportunities.
    García-Velasco JA, Pellicer A.
    Clin Transl Oncol. 9:681-2, 2007.

  • Systemic methotrexate to treat ectopic pregnancy does not affect ovarian reserve.
    Oriol B, Barrio A, Pacheco A, Serna J, Zuzuarregui JL, García-Velasco JA.
    Fertil Steril. 90:1579-82, 2008.

  • High-dose recombinant LH add-back strategy using high-dose GnRH antagonist is an innovative protocol compared with standard GnRH antagonist.
    García-Velasco JA, Coelingh Bennink HJ, Epifanio R, Escudero E, Pellicer A, Simón C.
    Reprod Biomed Online. 15:280-7, 2007.

  • Extended embryo culture to increase implantation rate.
    Quea G, Romero K, García-Velasco JA.
    Reprod Biomed Online. 14:375-83, 2007.

  • Extended embryo culture to increase implantation rate.
    Quea G, Romero K, García-Velasco JA.
    Reprod Biomed Online. 2007.

  • Aromatase inhibitors in ovarian stimulation.
    García-Velasco JA.
    Reprod Biomed Online. 13:906, 2006.

  • Serum interleukin-6 levels are elevated in women with minimal-mild endometriosis.
    Martínez S, Garrido N, Coperias JL, Pardo F, Desco J, García-Velasco JA, Simón C, Pellicer A.
    Hum Reprod. 22:836-42, 2007.

  • Vascular endothelial cadherin regulates vascular permeability: Implications for ovarian hyperstimulation syndrome.
    Villasante A, Pacheco A, Ruiz A, Pellicer A, García-Velasco JA.
    J Clin Endocrinol Metab. 92:314-21, 2007.

  • Crossmodal audio-visual interactions in the primary visual cortex of the visually deprived cat: a physiological and anatomical study.
    Sanchez-Vives MV, Nowak LG, Descalzo VF, García-Velasco JA, Gallego R, Berbel P.
    Prog Brain Res. 155:287-311, 2006.

  • Sperm cryopreservation in oncological patients: a 14-year follow-up study.
    Meseguer M, Molina N, García-Velasco JA, Remohí J, Pellicer A, Garrido N.
    Fertil Steril. 85:640-5, 2006.

  • Coasting for the prevention of ovarian hyperstimulation syndrome: much ado about nothing?
    García-Velasco JA, Isaza V, Quea G, Pellicer A.
    Fertil Steril. 85:547-54, 2006.

  • Plasma levels of soluble vascular endothelial growth factor receptor-1 may determine the onset of early and late ovarian hyperstimulation syndrome.
    Pau E, Alonso-Muriel I, Gómez R, Novella E, Ruiz A, García-Velasco JA, Simón C, Pellicer A.
    Hum Reprod. 21:1453-60, 2006.

  • Long-term pituitary down-regulation before in vitro fertilization (IVF) for women with endometriosis.
    Sallam HN, García-Velasco JA, Dias S, Arici A.
    Cochrane Database Syst Rev. 2006.

  • Medical treatment of endometriosis.
    García-Velasco JA, Quea G.
    Minerva Ginecol. 57:249-55, 2005.

  • Impact of endometrioma resection prior to IVF/ICSI cycles.
    García-Velasco JA, Arici A, Pellicer A.
    Am J Obstet Gynecol. 193:594-5, 2005.

  • The aromatase inhibitor letrozole increases the concentration of intraovarian androgens and improves in vitro fertilization outcome in low responder patients: a pilot study.
    García-Velasco JA, Moreno L, Pacheco A, Guillén A, Duque L, Requena A, Pellicer A.
    Fertil Steril. 84:82-7, 2005.

  • How would revealing the identity of gamete donors affect current practice?
    García-Velasco JA, Garrido N.
    Reprod Biomed Online. 10:564-6, 2005.

  • Effect of repeated assisted reproduction techniques on the ovarian response.
    Serna J, García-Velasco JA.
    Curr Opin Obstet Gynecol. 17:233-6, 2005.

  • 139. E-learning in reproductive medicine.
    García-Velasco JA, Schneider J.
    Hum Reprod. 20:569-70, 2005.

  • Extended coasting duration exerts a negative impact on IVF cycle outcome due to premature luteinization.
    Moreno L, Diaz I, Pacheco A, Zúñiga A, Requena A, García-Velasco JA.
    Reprod Biomed Online. 9:500-4, 2004.

  • Coasting acts through downregulation of VEGF gene expression and protein secretion.
    García-Velasco JA, Zúñiga A, Pacheco A, Gómez R, Simón C, Remohí J, Pellicer A.
    Hum Reprod. 19:1530-8, 2004.

  • Surgery for the removal of endometriomas before in vitro fertilization does not increase implantation and pregnancy rates.
    García-Velasco JA, Arici A.
    Fertil Steril. 81:1206, 2004.

  • Removal of endometriomas before in vitro fertilization does not improve fertility outcomes: a matched, case-control study.
    García-Velasco JA, Mahutte NG, Corona J, Zúñiga V, Gilés J, Arici A, Pellicer A.
    Fertil Steril. 81:1194-7, 2004.

  • Medical treatment of endometriosis.
    Simón C, García-Velasco JA.
    Gynecol Obstet 57:51-2, 2004.

  • Clinical experience and perinatal outcome of blastocyst transfer after coculture of human embryos with human endometrial epithelial cells: a 5-year follow-up study.
    Mercader A, García-Velasco JA, Escudero E, Remohí J, Pellicer A, Simón C.
    Fertil Steril. 80:1162-8, 2003.

  • Apoptosis and the pathogenesis of endometriosis.
    García-Velasco JA, Arici A.
    Semin Reprod Med. 21:165-72, 2003.

  • New concepts in the understanding of the ovarian hyperstimulation syndrome.
    García-Velasco JA, Pellicer A.
    Curr Opin Obstet Gynecol. 15:251-6, 2003.

  • Factors that determine discordant outcome from shared oocytes.
    García-Velasco JA, Isaza V, Caligara C, Pellicer A, Remohí J, Simón C.
    Fertil Steril. 80:54-60, 2003.

  • Early maternal hypothyroxinemia alters histogenesis and cerebral cortex cytoarchitecture of the progeny.
    Lavado-Autric R, Ausó E, García-Velasco JA, Arufe Mdel C, Escobar del Rey F, Berbel P, Morreale de Escobar G.
    J Clin Invest. 111:1073-82, 2003.

  • Recombinant vs. urinary follicle-stimulating hormone in couples undergoing intrauterine insemination. A randomized study.
    Isaza V, Requena A, García-Velasco JA, Remohí J, Pellicer A, Simón C.
    J Reprod Med. 48:112-8, 2003.

  • Elevated soluble Fas ligand levels may suggest a role for apoptosis in women with endometriosis.
    García-Velasco JA, Mulayim N, Kayisli UA, Arici A.
    Fertil Steril. 78:855-9, 2002.

  • Transabdominal ultrasound-guided embryo transfer does not increase pregnancy rates in oocyte recipients.
    García-Velasco JA, Isaza V, Martinez-Salazar J, Landazábal A, Requena A, Remohí J, Simón C.
    Fertil Steril. 78:534-9, 2002.

  • Regulation of fas ligand expression by IL-8 in human endometrium.
    Selam B, Kayisli UA, García-Velasco JA, Akbas GE, Arici A.
    J Clin Endocrinol Metab. 87:3921-7, 2002.

  • Oocyte and embryo quality after coasting: the experience from oocyte donation.
    Isaza V, García-Velasco JA, Aragonés M, Remohí J, Simón C, Pellicer A.
    Hum Reprod. 17:1777-82, 2002.

  • Estradiol down-regulates MCP-1 expression in human coronary artery endothelial cells.
    Seli E, Pehlivan T, Selam B, García-Velasco JA, Arici A.
    Fertil Steril. 77:542-7, 2002.

  • The "vanishing embryo" phenomenon in an oocyte donation programme.
    Rodríguez-González M, Serra V, García-Velasco JA, Pellicer A, Remohí J.
    Hum Reprod. 17:798-802, 2002.

  • The endometrium versus embryonic quality in endometriosis-related infertility.
    Garrido N, Navarro J, García-Velasco JA, Remoh J, Pellice A, Simón C.
    Hum Reprod Update. 8:95-103, 2002

  • Protracted expression of serotonin transporter and altered thalamocortical projections in the barrelfield of hypothyroid rats.
    Ausó E, Cases O, Fouquet C, Camacho M, García-Velasco JA, Gaspar P, Berbel P.
    Eur J Neurosci.14:1968-80, 2001

  • Extracellular matrix-dependent regulation of Fas ligand expression in human endometrial stromal cells.
    Selam B, Kayisli UA, García-Velasco JA, Arici A.
    Biol Reprod. 66:1-5, 2002.

  • Human ovarian steroid secretion in vivo: effects of GnRH agonist versus antagonist (cetrorelix).
    García-Velasco JA, Isaza V, Vidal C, Landazábal A, Remohí J, Simón C, Pellicer A.
    Hum Reprod. 16:2533-9, 2001.

  • Role of thyroid hormones in the maturation and organisation of rat barrel cortex.
    Berbel P, Ausó E, García-Velasco JA, Molina ML, Camacho M.
    Neuroscience. 107:383-94, 2001.

  • Endometrial quality in infertile women with endometriosis.
    Pellicer A, Navarro J, Bosch E, Garrido N, García-Velasco JA, Remohí J, Simón C.
    Ann N Y Acad Sci. 943:122-30, 2001.

  • Endocrinological and ultrasonographic variations after immature oocyte retrieval in a natural cycle.
    Requena A, Neuspiller F, Cobo AC, Aragonés M, García-Velasco JA, Remohí J, Simón C, Pellicer A.
    Hum Reprod. 16:1833-7, 2001.

  • Blastocyst transfer: does it really affect the outcome?
    García-Velasco JA, Simón C.
    Curr Opin Obstet Gynecol. 13:299-304, 2001.

  • Endometrial receptivity in terms of pinopode expression is not impaired in women with endometriosis in artificially prepared cycles.
    García-Velasco JA, Nikas G, Remohí J, Pellicer A, Simón C.
    Fertil Steril. 75:1231-3, 2001.

  • Clinical experience employing co-culture of human embryos with autologous human endometrial epithelial cells.
    Rubio C, Simón C, Mercader A, García-Velasco JA, Remohí J, Pellicer A.
    Hum Reprod. 15 Suppl 6:31-8, 2000.

  • Regulation of fas ligand expression in breast cancer cells by estrogen: functional differences between estradiol and tamoxifen.
    Mor G, Kohen F, García-Velasco JA, Nilsen J, Brown W, Song J, Naftolin F.
    J Steroid Biochem Mol Biol. 73:185-94, 2000.

  • High doses of gonadotrophins combined with stop versus non-stop protocol of GnRH analogue administration in low responder IVF patients: a prospective, randomized, controlled trial.
    García-Velasco JA, Isaza V, Requena A, Martínez-Salazar FJ, Landazábal A, Remohí J, Pellicer A, Simón C.
    Hum Reprod 15:2292-6, 2000.

  • Empty follicle syndrome: evidence for recurrence.
    Zreik TG, García-Velasco JA, Vergara TM, Arici A, Olive D, Jones EE.
    Hum Reprod. 15:999-1002, 2000.

  • Endogenous LH surge detection versus administration of HCG to correctly time intrauterine insemination: which provides a better pregnancy rate?
    García-Velasco JA, Arici A, Zreik TG.
    Hum Reprod. 15:975-6, 2000.

  • Is the endometrium or oocyte/embryo affected in endometriosis?
    García-Velasco JA, Arici A.
    Hum Reprod. 14 Suppl 2:77-89, 1999.

  • Unicornuate uterus with a rudimentary horn and ovarian dysgerminoma. A case report.
    Zreik TG, Pustilnik TB, García-Velasco JA, Rutherford TJ, Troiano RN, Olive DL.
    J Reprod Med. 44:1025-8, 1999.

  • Interleukin-8 expression in endometrial stromal cells is regulated by integrin-dependent cell adhesion.
    García-Velasco JA, Arici A.
    Mol Hum Reprod. 5:1135-40, 1999.

  • Coculture of human embryos with autologous human endometrial epithelial cells in patients with implantation failure.
    Simón C, Mercader A, García-Velasco JA, Nikas G, Moreno C, Remohí J, Pellicer A.
    J Clin Endocrinol Metab. 84:2638-46, 1999.

  • Interleukin-8 stimulates the adhesion of endometrial stromal cells to fibronectin.
    García-Velasco JA, Arici A.
    Fertil Steril. 72:336-40, 1999.

  • Regulation of monocyte chemotactic protein-1 expression in human endometrial stromal cells by integrin-dependent cell adhesion.
    García-Velasco JA, Seli E, Arici A.
    Biol Reprod. 61 :548-52, 1999.

  • Macrophage derived growth factors modulate Fas ligand expression in cultured endometrial stromal cells: a role in endometriosis.
    García-Velasco JA, Arici A, Zreik T, Naftolin F, Mor G.
    Mol Hum Reprod. 5:642-50, 1999.

  • Prospective, randomized, crossover study to evaluate the benefit of human chorionic gonadotropin-timed versus urinary luteinizing hormone-timed intrauterine inseminations in clomiphene citrate-stimulated treatment cycles.
    Zreik TG, García-Velasco JA, Habboosh MS, Olive DL, Arici A.
    Fertil Steril. 71:1070-4, 1999.

  • Chemokines and human reproduction.
    García-Velasco JA, Arici A
    Fertil Steril. 71:983-93. 1999.

  • A prospective, randomized, double-blind clinical trial to study the efficacy and efficiency of a fixed dose of recombinant follicle stimulating hormone (Puregon) in women undergoing ovarian stimulation.
    Out HJ, Lindenberg S, Mikkelsen AL, Eldar-Geva T, Healy DL, Leader A, Rodriguez-Escudero FJ, García-Velasco JA, Pellicer A.
    Hum Reprod. 14:622-7. 1999.

  • Potential implications of chemokines in reproductive function: an attractive idea.
    Simón C, Caballero-Campo P, García-Velasco JA, Pellicer A.
    J Reprod Immunol. 38: 169-93. 1998.

  • Increasing uterine receptivity by decreasing estradiol levels during the preimplantation period in high responders with the use of a follicle-stimulating hormone step-down regimen.
    Simón C, García-Velasco JA, Valbuena D, Peinado JA, Moreno C, Remohí J, Pellicer A.
    Fertil Steril. 70:234-9, 1998.

  • Increasing the length of the middle crura for better tip projection in primary rhinoplasty.
    García-Velasco JA, Vidal JT, García-Casas S.
    Aesthetic Plast Surg. 22:253-8, 1998.

  • A prospective, randomized trial of nifedipine vs. ritodrine in threatened preterm labor.
    García-Velasco JA, González González A.
    Int J Gynaecol Obstet. 61:239-44, 1998.

  • Rupture of an ovarian endometrioma during the first trimester of pregnancy.
    García-Velasco JAA, Alvarez M, Palumbo A, González-González A, Ordás J.
    Eur J Obstet Gynecol Reprod Biol. 76:41-3, 1998.

  • Endometrial thickness and serum oestradiol concentrations as predictors of outcome in oocyte donation.
    Remohí J, Ardiles G, García-Velasco JA, Gaitán P, Simón C, Pellicer A.
    Hum Reprod. 12 :2271-6, 1997.

  • Oocyte quality in polycystic ovaries revisited: identification of a particular subgroup of women.
    Cano F, García-Velasco JA, Millet A, Remohí J, Simón C, Pellicer A.
    J Assist Reprod Genet. 14:254-61, 1997.

  • Maternal serum creatine kinase: a possible predictor of tubal pregnancy?
    García-Velasco JA, Requena A, Santisteban J.
    Am J Obstet Gynecol. 175:238-40, 1996.

  • Cytokines-adhesion molecules-invasive proteinases. The missing paracrine/autocrine link in embryonic implantation?
    Simón C, Gimeno MJ, Mercader A, Francés A, García-Velasco JA, Remohí J, Polan ML, Pellicer A.
    Mol Hum Reprod. 2:405-24. 1996.


Read more

Videos

Endometrial Immunology
Close Menu